ABSTRACT
Non-standard Abbreviations and Acronyms:
ath-159a
Arabidopsis thaliana-159a We have previously reported on the substantial lowering effect of cigarette smoking on circulating IL-12 levels in patients with coronary artery disease (CAD) 5 . Similar effects have been observed in bronchoalveolar lavage and gingival crevicular fluid of current smokers 6;7 In vitro studies have reported decreased IL-12p40 mRNA levels in macrophages exposed to cigarette smoke extract (CSE), probably mediated by enhanced levels of the p40 transcriptional repressor c-fos 8 . Independent of cell-type or species origin, exposure of CSE has further been described in in vitro studies to modify INFƴ expression and to impair INFƴ signaling, although contradictory reported [9] [10] [11] [12] .
ASCET
MicroRNAs (miRNAs) are naturally occurring short non-coding RNA molecules that regulate the expression of target genes post-transcriptionally, by messenger RNA (mRNA) degradation and/or translational inhibition. MiRNAs can be released by cells into the circulation in association with micro-particles, exosomes, or specific proteins, thus serving as potential 15 .
Genetic variability of the IL-12 genes may also influence the extent of IL-12 production.
Many studies have focused on the polymorphic site at position 1188 in the 3' UTR of the IL12p40 gene, which was reported to increase in vitro IL-12 secretion rather than to increase levels of the single IL-12p40 subunit 16 . The 1188 C-allele, also associated with decreased IL-12p40 serum levels 17 , has been reported to increase the overall risk of cancers 18 and was further associated with increased risk of bladder cancer in cigarette smokers 19 indicating a IL-12p40
gene-environment interaction.
According to our previous findings of low IL-12 levels in smokers, we aimed in the present study to investigate the influence of cigarette smoke on markers involved in the IL- 
MATERIALS and METHODS

Subjects
The present investigation is a sub-study of the ASCET trial in Norway 20 21 , which included 1001 patients with stable CAD (97% Caucasians, 78% men, 20 % current smokers, were selected for miR-21 analysis, to equalize numbers of smokers and non-smokers.
Ethics Statement
The ASCET study was performed according to the Declaration of Helsinki and approved by The Regional Committee of Medical Research Ethics in South-Eastern Norway. All subjects gave their written informed consent to participate. The ASCET trial is registered at clinicaltrials.gov, with the identification number NCT00222261.
Blood Sampling and standard biochemical analyses
In fasting condition, between 8.00-10.00 a.m., blood samples were collected at entrance into the ASCET study. Routine analyses were performed by conventional methods.
Ethylenediaminetetraacetic acid (EDTA) plasma was prepared by centrifugation within 30 minutes, at 2500 x g at 4°C for 20 minutes for plasma miRNA isolation. EDTA blood and PAXGene tubes were collected for DNA and total RNA extraction, respectively. All material was kept frozen at -80°C until further processing and analysis.
Isolation procedures
Prior to the isolation of miRNAs, EDTA plasma was additionally processed with an extra centrifugation step at 16.000 x g for 4°C in 5 minutes. MiRNAs were subsequently isolated from the supernatant of 200 samples, 100 current smokers and 100 non-smokers matched by age and gender, by use of magnetic beads and the TaqMan miRNA ABC Purification kit, Panel A (Applied Biosystems by Life Technologies, Foster City, CA, USA). Prior to miRNA purification, all samples were spiked with 2 μl of 1 nM Arabidopsis thaliana miR-159a (ath-miR159a) according to manufacturers' protocol, to control for differences in recovery during the isolation procedure and further amplification efficiency.
Briefly, 100 μl lysis buffer was added to 50 μl plasma and the miRNAs were hybridized to the magnetic beads and further eluted in 100 μl elution buffer and stored at -80°C until analysis. The Panel A of the purification kit isolates 377 specific miRNAs, including miR-21 and the selected reference genes.
Total RNA was extracted from 330 samples, using PAXGene Blood RNA kit (PreAnalytix, Qiagen, Germany), with an extra cleaning step (RNeasy MinElute Cleanup Kit, Qiagen). Circulating leukocytes were hence the source for RNA. Briefly, RNA was extracted using ethanol and spin columns and eluted in 14 μl elution buffer and stored at -80°C until analysis.
DNA was automatically isolated from 1001 EDTA whole-blood samples by the MagNA Pure LC DNA Isolation kit on the MagNA Pure LC instrument (Roche Diagnostics, Germany). In brief, DNA was isolated from 500 μl whole-blood by magnetic beads and eluted in 100 μl elution buffer and stored at -80°C until analysis.
Concentration and purity of extracted RNA and DNA were assessed using NanoDrop 1000 spectrophotometry (NanoDrop Technologies, DE, USA). Additionally, for this validation experiment, no influence on expression by cigarette smoke was essential for the choice.
Reference genes tested for normalization in the miR-21 analysis
IL-12 p40 genotyping
Allelic discrimination of the polymorphism IL-12p40 3'UTR 1188 A/C (rs3212227, confidence. About 5% of the samples were reanalyzed, with 100 % concordance.
Relative real-time PCR quantification of miRNAs and mRNAs
Expression of all genes was measured on the VIIa 7 instrument using TaqMan Universal polymerase chain reaction (PCR) Master Mix, No AmpErase UNG and TaqMan assays (Applied Biosystems), as relative quantification (RQ) (2 -ΔΔCt method) 27 .
The spike-in ath-miR-159a in combination with miR-425 was used as endogenous controls for normalization of miR-21 expression. Reverse transcription and expression analysis of miR-21, miR-425 and ath-miR-159a was performed and analyzed using the TaqMan MicroRNA Reverse
Transcription kit with the application of 5 μl miRNA, and the miR assays (IDs: 000397, 001516, 000338, respectively). The miR assays contain primers for each individual miR for the reverse transcription step and specific primers and probes for the PCR step.
Total RNA (100 ng) was reversely transcribed into complementary DNA (cDNA) by use of qScript cDNA SuperMix, using oligo (dTs) and random primers (Quanta Biosciences, Inc., Gaithersburg, USA). Expression of the IL-12p35 (Hs01073447_m1), IL-12p40 (Hs01011518_m1) and INFƴ (Hs00989291_m1) genes were normalized to β-2 macroglobulin (Hs99999907_m1) expression levels, previously tested as a valid house-keeping gene in this population 28 .
The PCR reaction for miRNAs and mRNA targets were carried out in volumes of 20 μl, with application of 1.33 μl and 2 μl cDNA, respectively. Individual amplification curves for all assays were carefully validated. Samples with Ct values >35 were not included in the data analysis, and template-negative controls were included in each run.
Statistics
As the measured variables were unequally distributed, non-parametric tests were applied.
For group comparisons, Kruskal-Wallis and Mann-Whitney tests, when appropriate, were used for continuous data and the χ 2 test for categorical data. The associations between the markers and cigarette smoking were analyzed by linear regression using log transformed data. The models were adjusted for age, gender and C-reactive protein (CRP) in miR-21 association (cf. Hardy-Weinberg equilibrium (HWE) was tested for the IL-12p40 polymorphism using the χ 2 test.
All statistical analyses were performed by SPSS 21.0 (SPSS Inc., Chicago, Illinois, USA). A two-tailed probability test of 0.05 or less was considered statistically significant.
RESULTS
Demographic data in the miR-21 cohort (n = 200) according to cigarette smoking are presented in Table 1 , showing similar distribution of the variables between current smokers and non-smokers, except of higher CRP values in the smoking group. We have previously reported on the lowering effect of smoking on circulating IL-12 in the total ASCET population (n = 1001) 5 . In the present miR-21 cohort, circulating IL-12 was similarly and significantly lower (43%) in current smokers vs. non-smokers (51 pg/mL vs.89 pg/mL, adjusted p-value < 0.001).
MiR-21 expression
The isolation and analysis of miR-21 was successfully performed in plasma samples from 
Gene-expression of IL-12p35, IL-12p40 and INFƴ
Expression of the genes in circulating leukocytes was analyzed in 330 patients (96 current smokers). Demographic data in this cohort are shown in Online Supplement Table 1 . IL12p35 was significantly downregulated in current smokers (p = 0.014, adjusted) (Figure 2A ), whereas expression of IL-12p40 mRNA was not detectable. In patients with the particularly low circulating IL-12 levels, IL-12p35 mRNA levels were observed additionally reduced in current smokers and especially in heavy smokers (p = 0.045, adjusted) ( Figure 2B ).
Expression of INFƴ was not differently expressed between smokers and non-smokers and also not between the 4 smoking groups (p >2.0, both), however, a borderline reduction in INFƴ mRNA levels was observed in heavy smokers (category 3) vs. smokers in category 2 (p = 0.057) ( Figure 2C ).
Genotyping of the IL-12p40 polymorphism
The IL-12 p40 1188A/C polymorphism was successfully analyzed in 992 subjects and the AA (n = 651), AC (n = 309) and CC (n = 32) genotype distribution was in HWE. Demographic data in the total ASCET cohort are shown in Online Supplementary levels as compared to A-allele carriers (p = 0.006, adjusted) ( Figure 3A ). When stratified according to smoking or not, this association was only present in the non-smoking group (p = 0.012, adjusted) ( Figure 3B ).
Association analyses
We observed a weak but significant correlation between miR-21 and circulating IL-12 (r and strengthened in the non-smoking group (r = 0.36, p<0.001, n = 97).
We also observed that angiotensin II receptor blocker and insulin significantly induced elevated levels of circulating IL-12 and mir-21 (only insulin) (p<0.05, both, data not shown).
Summary of results
A schematic illustration of the overall achieved results is presented in Figure 4 . 
Legend to Figure1: Expression of miR-21
Expression of miR-21 as related to cigarette smoking in the total miR-21 cohort (A), and in the subgroup of subjects presenting with low IL-12 levels (< 37 pg/mL; 25 percentile in current smokers) (B).
White bars; non-smokers, grey bars; current smokers RQ: relative quantification p-values refer to differences in relative expression of miR-21 between non-smokers and current smokers (*adjusted for age, sex, Creactive protein, use of angiotensin II receptor blocker and insulin).
Error bars represent the 25-and 75 percentiles. Influence of the IL-12p40 1188 A/C polymorphism on circulating IL-12 levels in the total cohort (A) and stratified according to smoking/non-smoking (B). White, light grey and dark grey bars refer to AA, AC and CC genotypes.
p-values refer to differences in IL-12 levels between CC and AA/AC genotypes (adjusted for age, sex, the presence of hypertension, C-reactive protein, triglycerides, total cholesterol, high-density lipoprotein cholesterol, use of angiotensin II receptor blocker and insulin).
Error bars represent the 25-and 75 percentiles. Full-lines indicate further the observed significant association between the IL-12p40 +1188 A/C polymorphism and elevated circulating levels of the heterodimer IL-12.
The broken-line arrows indicate that 1) It is not clear wether cigarette smoking affects the influence of the IL-12p40 +1188 A/C polymorphism on circulating IL-12 levels and 2) Our results on the influence of cigarette smoking on miR-21 cannot explain the lower circulating levels of the heterodimer IL-12.
In total, cigarette smoking seems to attenuate the pro-inflammatory axis, including INFƴ and the TH1-cell response, which partly may explain why smokers have impaired immunity. The observed effects may be modulated by the IL-12p40+1188A/C polymorphism.
SNP; single nucleotide polymorphism
DISCUSSION
Our hypothesis of increased miR-21 expression in current smokers could have explained the previously reported lower circulating IL-12 levels in these subjects. However, cigarette smoking was significantly associated with lower expression of miR-21 ( Figure 1A ) and its target IL-12p35 mRNA (Figure 2 A) in the present study. Hence, our miR-21 results cannot clarify the pronounced reduction in circulating IL-12 in current smokers, although in a small group of patients with particular low IL-12 levels, miR-21 was significantly upregulated in smokers ( Figure 1B) , with corresponding additionally lower IL-12p35mRNA levels ( Figure 2B ). Other unknown/unmeasured miR-21 co-stimulating factors/regulators in these subjects might thus be suggested. INFƴ was not significantly affected by smoking in general, however, a tendency of repressed INFƴ gene-expression related to degree of smoking was observed ( Figure 2C ).
Modified expression of miR-21 has been described as related to CSE exposure and tobacco use in experimental and human studies, however contradictory reported 30 . The discrepancy may be due to type and duration of exposure. Differences in analytical models, i.e. Moreover, hemolytic plasma samples were not utilized for miRNA isolation, and in an attempt of diminishing cellular debris, an additional centrifugation step was performed prior to isolation.
The spike-in ath-mir-159a added to all 200 samples before the isolation procedure, controls additionally for the isolation procedure, and further processing with the conversion of miRNAs to cDNA, and PCR efficiency. The applied spike control in the present investigation was successfully recovered in 99.5% of the samples.
Influence of the studied IL-12p40 polymorphism on circulating IL-12 levels was especially present in non-smokers ( Figure 3B ). Lack of similar significant increase in IL-12 with increasing number of C-alleles in smokers, may probably be due to the low number with respective genotypes. Interestingly, IL-12 levels associating with the CC genotype in smokers were similar to IL-12 levels in non-smoking A-allele carriers ( Figure 3B ). In atherosclerosis, it might thus be suggested a beneficial AA/AC genotype in non-smokers, and further a superior CC genotype in smokers as related to IL-12' role in immunity and anti-tumor activity. The latter has, however, been contradictory reported in a smaller study on the risk of bladder cancer 19 .
A positive correlation was observed between circulating IL-12 and expression of miR-21.
MiR-21 was not correlated to IL-12p35-mRNA, however, parallelly altered in current smokers.
Thus, our results may indicate miR-21 to be a modest repressor of IL-12p35mRNA, as IL-12 and miR-21 expression seem to mirror each other rather than being inversely correlated. The IL-12/INFƴ pro-inflammatory axis, in which smoking seems to potentiate the interplay between the investigated markers, may involve regulatory mechanisms additional to miR-21.
MiR-21 was, in addition to smoking habit, observed correlated to CRP, supporting the previously described association between miR-21 and inflammation 31 .
The low IL-12 levels observed in smokers may have clinical implications concerning both inflammation and malignancies. The impaired immunity described in airways of current smokers may partly be addressed by the observed attenuated IL-12 gene-and protein expression in the circulation, and further the reported IL-12 modifications in experimental studies 6;7 . IL-12
has emerged as one of the most potent cytokines in mediating antitumor activity 32 . Bioinformatically predicted targets for miR-21 are mainly tumor suppressor genes, including IL12p35 and further also the protein entitled Programmed Cell Death 4 (PDCD4). Loss of PDCD4 has been associated with increased tumor aggressiveness 33 , and PDCD4 was similarly reported to be lower expressed in current smokers 34 . As all these variables may be dysregulated in current smokers, the observations may partly explain why current smokers are reported to have an increased risk of many types of cancers.
Whether nicotine contributes or causes our observed associations is uncertain, as cigarette smoke contains numerous established carcinogens, and further tobacco-specific nitrosamines that produce reactive oxygen species 35 mediating multiple harmful effects including atherosclerosis.
Thus, detailed effects of the cigarette smoke need to be focused to identify which are addressing the different components.
As shown from the Online Supplementary Table 2 , angiotensin II receptor blocker and insulin were more frequently used in the non-smoking group as compared to current smokers, and we also observed that these drugs induced elevated levels of circulating IL-12 and mir-21.
As patients with CAD commonly are treated with these drugs, this is worth to be noticed. Aspirin and angiotensin converting enzyme (ACE) -inhibitors have previously been reported to suppress IL-12 production in leukocytes 36;37 . In the present investigation, all patients were on aspirin treatment at time of inclusion and ACE-inhibitors were not differently distributed according to smoking groups and not associated with modified IL-12-levels, thus not corrected for.
Limitations
Mir-21 regulates multiple genes and IL-12 may as well be regulated by other miRNAs.
Additionally, miR-21 is most likely under strict regulation by other regulatory mechanisms i.e.
long non-coding RNA molecules, which are capable of binding up excessive amounts of miRNAs preventing them from inhibiting their mRNA targets. One such example is growth arrest-specific 5 (GAS5) 38 . In light of miRNAs' promiscuity and complexity concerning their function, along with small numbers in the sub-group analysis, the present study should be regarded as experimental.
Conclusion
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